Multifocal nivolumab immune-related adverse effects during asymptomatic SARS-CoV-2 infection: causality or casuality?

Dinoto, Alessandro; Rossato, Francesco; Corradetti, Tommaso; Gioulis, Manuela; Marsala, Sandro Zambito; Ferracci, Franco

Dinoto, Alessandro; Rossato, Francesco; Corradetti, Tommaso; Gioulis, Manuela; Marsala, Sandro Zambito; Ferracci, Franco.

Dinoto A; Neurology Unit, "San Martino" Hospital, AULSS 1 - Dolomiti, Viale Europa, 22, 32100, Belluno, Italy. alessandro.dinoto@hotmail.it.
Rossato F; Neurology Clinic, Neuroscience Department, University of Padua, Padua, Italy.
Corradetti T; Neurology Unit, "San Martino" Hospital, AULSS 1 - Dolomiti, Viale Europa, 22, 32100, Belluno, Italy.
Gioulis M; Neurology Unit, "San Martino" Hospital, AULSS 1 - Dolomiti, Viale Europa, 22, 32100, Belluno, Italy.
Marsala SZ; Neurology Unit, "San Martino" Hospital, AULSS 1 - Dolomiti, Viale Europa, 22, 32100, Belluno, Italy.
Ferracci F; Neurology Unit, "San Martino" Hospital, AULSS 1 - Dolomiti, Viale Europa, 22, 32100, Belluno, Italy.

Neurol Sci ; 43(5): 2967-2968, 2022 05.

Article in English | MEDLINE | ID: covidwho-1661702

Subject(s)

COVID-19; Nivolumab; Causality; Humans; Nivolumab/adverse effects; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Nivolumab / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: Neurol Sci Journal subject: Neurology Year: 2022 Document Type: Article Affiliation country: S10072-022-05916-0

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google